Logo image of AIL.DE

AIR LIQUIDE SA (AIL.DE) Stock Fundamental Analysis

FRA:AIL - Deutsche Boerse Ag - FR0000120073 - Common Stock - Currency: EUR

168.34  +0.64 (+0.38%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AIL. AIL was compared to 60 industry peers in the Chemicals industry. While AIL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. AIL has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

AIL had positive earnings in the past year.
In the past year AIL had a positive cash flow from operations.
AIL had positive earnings in each of the past 5 years.
AIL had a positive operating cash flow in each of the past 5 years.
AIL.DE Yearly Net Income VS EBIT VS OCF VS FCFAIL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

1.2 Ratios

Looking at the Return On Assets, with a value of 6.17%, AIL is in the better half of the industry, outperforming 77.19% of the companies in the same industry.
AIL's Return On Equity of 12.46% is amongst the best of the industry. AIL outperforms 80.70% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.25%, AIL belongs to the top of the industry, outperforming 85.96% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AIL is above the industry average of 6.58%.
The last Return On Invested Capital (9.25%) for AIL is above the 3 year average (8.90%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.17%
ROE 12.46%
ROIC 9.25%
ROA(3y)5.81%
ROA(5y)5.67%
ROE(3y)12.09%
ROE(5y)12.25%
ROIC(3y)8.9%
ROIC(5y)8.52%
AIL.DE Yearly ROA, ROE, ROICAIL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10

1.3 Margins

AIL has a better Profit Margin (11.15%) than 85.96% of its industry peers.
AIL's Profit Margin has improved in the last couple of years.
AIL has a better Operating Margin (18.36%) than 92.98% of its industry peers.
In the last couple of years the Operating Margin of AIL has grown nicely.
AIL has a Gross Margin of 59.62%. This is amongst the best in the industry. AIL outperforms 91.23% of its industry peers.
AIL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.36%
PM (TTM) 11.15%
GM 59.62%
OM growth 3Y-0.26%
OM growth 5Y2.26%
PM growth 3Y-2.11%
PM growth 5Y2.08%
GM growth 3Y-2.77%
GM growth 5Y-0.33%
AIL.DE Yearly Profit, Operating, Gross MarginsAIL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

4

2. Health

2.1 Basic Checks

AIL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AIL has been increased compared to 1 year ago.
AIL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AIL has been reduced compared to a year ago.
AIL.DE Yearly Shares OutstandingAIL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
AIL.DE Yearly Total Debt VS Total AssetsAIL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 3.70 indicates that AIL is not in any danger for bankruptcy at the moment.
The Altman-Z score of AIL (3.70) is better than 85.96% of its industry peers.
AIL has a debt to FCF ratio of 4.69. This is a neutral value as AIL would need 4.69 years to pay back of all of its debts.
The Debt to FCF ratio of AIL (4.69) is better than 75.44% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that AIL is not too dependend on debt financing.
AIL has a Debt to Equity ratio (0.44) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 4.69
Altman-Z 3.7
ROIC/WACC1.33
WACC6.95%
AIL.DE Yearly LT Debt VS Equity VS FCFAIL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.3 Liquidity

AIL has a Current Ratio of 0.77. This is a bad value and indicates that AIL is not financially healthy enough and could expect problems in meeting its short term obligations.
AIL's Current ratio of 0.77 is on the low side compared to the rest of the industry. AIL is outperformed by 94.74% of its industry peers.
AIL has a Quick Ratio of 0.77. This is a bad value and indicates that AIL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.57, AIL is not doing good in the industry: 92.98% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.57
AIL.DE Yearly Current Assets VS Current LiabilitesAIL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

3

3. Growth

3.1 Past

AIL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.41%.
Measured over the past 5 years, AIL shows a small growth in Earnings Per Share. The EPS has been growing by 7.69% on average per year.
AIL shows a decrease in Revenue. In the last year, the revenue decreased by -7.77%.
AIL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.61% yearly.
EPS 1Y (TTM)-4.41%
EPS 3Y7.94%
EPS 5Y7.69%
EPS Q2Q%-2.67%
Revenue 1Y (TTM)-7.77%
Revenue growth 3Y10.46%
Revenue growth 5Y5.61%
Sales Q2Q%-4.3%

3.2 Future

The Earnings Per Share is expected to grow by 12.31% on average over the next years. This is quite good.
Based on estimates for the next years, AIL will show a small growth in Revenue. The Revenue will grow by 4.15% on average per year.
EPS Next Y18.73%
EPS Next 2Y14.53%
EPS Next 3Y12.62%
EPS Next 5Y12.31%
Revenue Next Year-1.89%
Revenue Next 2Y1.63%
Revenue Next 3Y2.7%
Revenue Next 5Y4.15%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AIL.DE Yearly Revenue VS EstimatesAIL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
AIL.DE Yearly EPS VS EstimatesAIL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

AIL is valuated quite expensively with a Price/Earnings ratio of 31.88.
AIL's Price/Earnings is on the same level as the industry average.
AIL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.47, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 23.93, AIL is valued on the expensive side.
AIL's Price/Forward Earnings ratio is in line with the industry average.
AIL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.74.
Industry RankSector Rank
PE 31.88
Fwd PE 23.93
AIL.DE Price Earnings VS Forward Price EarningsAIL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AIL is valued a bit more expensive than the industry average as 61.40% of the companies are valued more cheaply.
The rest of the industry has a similar Price/Free Cash Flow ratio as AIL.
Industry RankSector Rank
P/FCF 34.62
EV/EBITDA 14.17
AIL.DE Per share dataAIL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
AIL has an outstanding profitability rating, which may justify a higher PE ratio.
AIL's earnings are expected to grow with 12.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.7
PEG (5Y)4.15
EPS Next 2Y14.53%
EPS Next 3Y12.62%

4

5. Dividend

5.1 Amount

AIL has a Yearly Dividend Yield of 1.72%.
Compared to an average industry Dividend Yield of 3.94, AIL has a dividend in line with its industry peers.
AIL's Dividend Yield is slightly below the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 1.72%

5.2 History

The dividend of AIL has a limited annual growth rate of 5.14%.
Dividend Growth(5Y)5.14%
Div Incr Years5
Div Non Decr Years5
AIL.DE Yearly Dividends per shareAIL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 1 2 3

5.3 Sustainability

AIL pays out 55.81% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of AIL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP55.81%
EPS Next 2Y14.53%
EPS Next 3Y12.62%
AIL.DE Yearly Income VS Free CF VS DividendAIL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B
AIL.DE Dividend Payout.AIL.DE Dividend Payout, showing the Payout Ratio.AIL.DE Dividend Payout.PayoutRetained Earnings

AIR LIQUIDE SA

FRA:AIL (2/4/2025, 7:00:00 PM)

168.34

+0.64 (+0.38%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-23 2024-10-23
Earnings (Next)02-21 2025-02-21/amc
Inst Owners27.76%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap97.34B
Analysts80
Price Target190.19 (12.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.72%
Yearly Dividend2.88
Dividend Growth(5Y)5.14%
DP55.81%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.87%
PT rev (3m)0.63%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.07%
EPS NY rev (3m)-1.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE 31.88
Fwd PE 23.93
P/S 3.53
P/FCF 34.62
P/OCF 15.83
P/B 3.94
P/tB 11.32
EV/EBITDA 14.17
EPS(TTM)5.28
EY3.14%
EPS(NY)7.03
Fwd EY4.18%
FCF(TTM)4.86
FCFY2.89%
OCF(TTM)10.63
OCFY6.32%
SpS47.74
BVpS42.71
TBVpS14.87
PEG (NY)1.7
PEG (5Y)4.15
Profitability
Industry RankSector Rank
ROA 6.17%
ROE 12.46%
ROCE 12.81%
ROIC 9.25%
ROICexc 9.67%
ROICexgc 16.3%
OM 18.36%
PM (TTM) 11.15%
GM 59.62%
FCFM 10.18%
ROA(3y)5.81%
ROA(5y)5.67%
ROE(3y)12.09%
ROE(5y)12.25%
ROIC(3y)8.9%
ROIC(5y)8.52%
ROICexc(3y)9.35%
ROICexc(5y)8.93%
ROICexgc(3y)16.12%
ROICexgc(5y)15.53%
ROCE(3y)11.88%
ROCE(5y)11.37%
ROICexcg growth 3Y3.56%
ROICexcg growth 5Y3.96%
ROICexc growth 3Y4.99%
ROICexc growth 5Y5.16%
OM growth 3Y-0.26%
OM growth 5Y2.26%
PM growth 3Y-2.11%
PM growth 5Y2.08%
GM growth 3Y-2.77%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 4.69
Debt/EBITDA 1.45
Cap/Depr 134.52%
Cap/Sales 12.08%
Interest Coverage 19.18
Cash Conversion 81.45%
Profit Quality 91.35%
Current Ratio 0.77
Quick Ratio 0.57
Altman-Z 3.7
F-Score7
WACC6.95%
ROIC/WACC1.33
Cap/Depr(3y)134.57%
Cap/Depr(5y)130.01%
Cap/Sales(3y)11.91%
Cap/Sales(5y)12.12%
Profit Quality(3y)96.12%
Profit Quality(5y)97.35%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.41%
EPS 3Y7.94%
EPS 5Y7.69%
EPS Q2Q%-2.67%
EPS Next Y18.73%
EPS Next 2Y14.53%
EPS Next 3Y12.62%
EPS Next 5Y12.31%
Revenue 1Y (TTM)-7.77%
Revenue growth 3Y10.46%
Revenue growth 5Y5.61%
Sales Q2Q%-4.3%
Revenue Next Year-1.89%
Revenue Next 2Y1.63%
Revenue Next 3Y2.7%
Revenue Next 5Y4.15%
EBIT growth 1Y4.24%
EBIT growth 3Y10.17%
EBIT growth 5Y8%
EBIT Next Year55.53%
EBIT Next 3Y21.6%
EBIT Next 5Y16.11%
FCF growth 1Y9.43%
FCF growth 3Y3.67%
FCF growth 5Y3.07%
OCF growth 1Y9.36%
OCF growth 3Y6.36%
OCF growth 5Y5.84%